Pacira Biosciences, Inc. (PCRX)
22.70
-0.09
(-0.39%)
USD |
NASDAQ |
Apr 02, 16:00
22.69
-0.01
(-0.04%)
After-Hours: 20:00
Pacira Biosciences Total Liabilities (Quarterly) : 571.81M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| Stryker Corp. | 25.42B |
| CorMedix, Inc. | 472.32M |
| Krystal Biotech, Inc. | 114.23M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.265B |
| Shareholders Equity (Quarterly) | 693.11M |
| Debt to Equity Ratio | 0.6034 |
| Current Ratio | 4.544 |
| Net Debt Paydown Yield | 4.25% |